A detailed history of Carnegie Lake Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Carnegie Lake Advisors LLC holds 20,250 shares of NVO stock, worth $2.22 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
20,250
Holding current value
$2.22 Million
% of portfolio
0.95%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$119.07 - $145.42 $2.41 Million - $2.94 Million
20,250 New
20,250 $2.41 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $248B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Carnegie Lake Advisors LLC Portfolio

Follow Carnegie Lake Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Lake Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Lake Advisors LLC with notifications on news.